📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC. (2022)

First Author: Sampson J

Attributed to: Driving innovation in precision medicine through translational life sciences research at the University of Leicester funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14030779

PubMed Identifier: 35159046

Publication URI: http://europepmc.org/abstract/MED/35159046

Type: Journal Article/Review

Volume: 14

Parent Publication: Cancers

Issue: 3

ISSN: 2072-6694